Patent details
EP3684333
Title:
HIGH DOSAGE VALBENAZINE FORMULATION AND COMPOSITIONS, METHODS, AND KITS RELATED THERETO
Basic Information
- Publication number:
- EP3684333
- PCT Application Number:
- US2018051579
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP187832282
- PCT Publication Number:
- WO2019060322
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- HIGH DOSAGE VALBENAZINE FORMULATION AND COMPOSITIONS, METHODS, AND KITS RELATED THERETO
- French Title of Invention:
- FORMULATION DE VALBENAZINE À DOSAGE ÉLEVÉ ET COMPOSITIONS, PROCÉDÉS ET KITS ASSOCIÉS
- German Title of Invention:
- HOCHDOSIERTE VALBENAZINFORMULIERUNG UND ZUSAMMENSETZUNGEN, VERFAHREN UND KITS DAZU
- SPC Number:
-
Dates
- Filing date:
- 18/09/2018
- Grant date:
- 05/03/2025
- EP Publication Date:
- 29/07/2020
- PCT Publication Date:
- 28/03/2019
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 05/03/2025
- EP B1 Publication Date:
- 05/03/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 18/09/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 26/02/2025
-
-
- Name:
- NEUROCRINE BIOSCIENCES, INC.
- Address:
- 12780 El Camino Real, San Diego, CA 92130, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 11/04/2025
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- O'BRIEN, Christopher F.
- Address:
- United States (US)
2
- Name:
- MCCLELLAND, Gregory A.
- Address:
- United States (US)
3
- Name:
- MOORE, Richard Alexander, Jr.
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201762561629 P
- Priority Date:
- 21/09/2017
- Priority Country:
- United States (US)
2
- Priority Number:
- 201762564951 P
- Priority Date:
- 28/09/2017
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
A61K 9/00;
A61K 47/12;
A61K 47/26;
A61K 47/36;
A61K 47/38;
A61K 9/48;
A61K 31/4745;
A61P 25/00;
Publication
European Patent Bulletin
- Issue number:
- 202510
- Publication date:
- 05/03/2025
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- 30/09/2025
- Annual Fee Number:
- 8
- Annual Fee Amount:
- 99 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-